The typical Ipamorelin researcher is an experienced lifter in their 30s or 40s who already knows what the natural GH pulse during slow-wave sleep is supposed to feel like and wants to amplify it without the cortisol or hunger spike that the older GHRPs cause. They often run it as half of the CJC-1295 + Ipamorelin pairing rather than solo.
Ipamorelin is a synthetic pentapeptide. Five amino acids. Molecular weight 711 Daltons. It was developed in the late 1990s by Helsinn Healthcare as a selective growth hormone secretagogue. Selective in this context means it triggers a GH pulse without dragging the cortisol, prolactin, ACTH, or aldosterone axis along for the ride. That selectivity is why it replaced GHRP-2 and GHRP-6 in nearly every modern protocol.
What Ipamorelin actually is
Sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH2. It is a peptide analog of ghrelin, the hunger hormone, but with the hunger-driving and cortisol-driving features deliberately bred out of the molecule. It binds the same growth hormone secretagogue receptor (GHSR-1a) on the anterior pituitary that ghrelin binds, but with a much narrower downstream signaling profile.
The mechanism in plain English
Your pituitary stores growth hormone in vesicles, ready to release in pulses. The biggest pulse of the day fires roughly an hour after sleep onset, during slow-wave sleep. Ipamorelin binds GHSR-1a and adds an extra trigger to that pulse, increasing both the amplitude and the duration. Critically, the trigger respects the pituitary's natural regulatory loop. You cannot blow the pituitary out the way you can with exogenous HGH. The released GH is your own.
Why selective matters
GHRP-6 was first to market. It worked, but it raised cortisol noticeably and triggered intense hunger via the ghrelin pathway. GHRP-2 followed. Cleaner on hunger, still spiked cortisol and prolactin. Ipamorelin closed both doors. Cortisol and prolactin stayed at baseline at standard research doses. For long-running protocols, the cortisol question matters: chronic cortisol elevation is bad news for sleep, recovery, and body composition, which are exactly the markers most researchers are trying to improve.
Quick reference table
| Spec | Value | Note |
|---|---|---|
| Sequence | Aib-His-D-2-Nal-D-Phe-Lys-NH2 | Pentapeptide, ~711 Da |
| Receptor | GHSR-1a | Same as ghrelin, selective signaling |
| Standard dose | 200 to 300 mcg, subq | Higher doses do not pulse more |
| Frequency | 1 to 3 times daily | Pre-bed dose most consistent across protocols |
| Cycle window | 8 to 12 weeks on, 4 weeks off | Receptor downregulation if pushed longer |
| Storage | 36 to 46 F after reconstitution | Use within 30 days post-reconstitution |
What GH-axis researchers track
Three markers move first. Sleep architecture (deep-sleep minutes on a wearable) shifts inside two weeks for most. Subjective recovery between training sessions follows. IGF-1 on a quarterly blood panel is the lab marker that confirms the GH axis is responding, usually rising 30 to 60 percent above baseline at standard research doses. Fasting glucose is worth tracking because the GH pulse has a modest counter-regulatory effect on insulin sensitivity. Body composition shifts are slower (12 weeks plus) and depend more on the training and nutrition behind them than on the peptide.
Why pre-bed is the dominant timing
The natural GH pulse fires during slow-wave sleep. Dosing Ipamorelin 30 to 60 minutes before bed amplifies that pulse rather than fighting the daytime glucose-driven GH suppression. Researchers running 2 or 3 doses per day usually add a fasted-morning dose and a pre-workout dose, but the pre-bed dose is the one nobody skips.
Compared to CJC-1295
CJC-1295 is a GHRH analog. It tells the pituitary to manufacture and prepare more growth hormone. Ipamorelin is a GHRP. It tells the pituitary to release a pulse of what is stored. The two stack additively because they hit different points in the same axis. This is why CJC-1295 + Ipamorelin is the most-prescribed GH peptide stack in the research community, not Ipamorelin alone.
External authority and source reading
Helsinn Healthcare published the original selectivity work in the late 1990s. The Raun et al. paper in European Journal of Endocrinology is the standard citation for the cortisol and prolactin neutrality finding. Subsequent reviews in Endocrine Reviews and the Journal of Clinical Endocrinology and Metabolism cover the GHRP class broadly and place Ipamorelin as the selective gold standard.
Compliance frame
Ipamorelin is not FDA-approved. It is sold in the US as research-use-only material for in-vitro and laboratory study. Aion ships Ipamorelin with research-grade labeling and a third-party COA. Any decision about your own use is a conversation for a qualified clinician familiar with peptide research.
Bottom line
Ipamorelin dominates the modern GH stack because it triggers the natural GH pulse without the cortisol, prolactin, and hunger noise that comes with the older GHRPs. Run pre-bed, pair with CJC-1295, cycle 8 to 12 weeks on with a 4-week break, and track sleep, IGF-1, and recovery. The selectivity is the whole story.